Volume 63, Pages 1-9 (December 2016)

Slides:

Advertisements

Similar presentations

The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Volume 47, Issue 12, Pages (December 2011)

Juan W. Valle, Sandrine Faivre, Richard A

Shin-Ichi Nishikawa, MD, PhD

Volume 64, Pages e1-e3 (January 2017)

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD

Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma? Dongrong Situ, MD, Junye Wang, MD, PhD, Peng Lin, MD, PhD,

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer.

Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.

Pain in cancer survivors; filling in the gaps

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer Peter M.

Hella E. Brandt, MA, Marcel E. Ooms, MD, PhD, Miel W

Tumors of the esophagogastric junction

Factors predictive of prognosis after esophagectomy for squamous cell cancer Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Thymoma—A Clinico-Pathological Long-Term Study with Emphasis on Histology and Adjuvant Radiotherapy Dose Thomas Harnath, MD, Alexander Marx, MD, Philipp.

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma Nader Abedallaa, MD, Lise Tremblay, MD, Charlotte.

Mariano Garcı́a-Yuste, MD, José M

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Treatment of Carcinoma of the Esophagus or Cardia*

P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients Matthias Kappler, Johanna Kotrba, Tom Kaune, Matthias Bache,

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Rebecca Holdsworth, Sehwang Liew JPRAS Open

Primary Cardiac Sarcoma

Volume 143, Issue 6, (December 2010)

Iris Metastasis in Small-Cell Lung Carcinoma

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers Jules L. Derks, MD Journal of.

Volume 17, Issue 2, Pages (February 1950)

Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer: A Prospective Intention-to-Treat Study Marcello Carlo Ambrogi,

Nabil P. Rizk, MD, Venkatraman E. Seshan, PhD, Manjit S

Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas? John M. Varlotto,

Discovery of biomarkers that diagnose kidney disease progression and novel patient management strategies needed now to prevent progressive kidney disease

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

Validation of the Proposed International Association for the Study of Lung Cancer Non- small Cell Lung Cancer Staging System Revisions for Advanced Bronchioloalveolar.

Osteoarthritis year 2012 in review: biology

Liver Transplantation for Hepatocellular Carcinoma

Recursive Partitioning Analysis Groups II–III Brain Metastases of Non-small Cell Lung Cancer: A Phase II Randomized Study Comparing Two Concurrent Chemoradiotherapy.

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Rocco Ricciardi, Robert D. Madoff, David A. Rothenberger, Nancy N

Carcinoma of the esophagus: Prognostic significance of histologic type

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

S-1 Treatment for Chemorefractory Thymic Carcinoma

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung Yung-Han Sun, MS, Shih-Wei Lin, PhD, Chih-Cheng Hsieh, MD,

Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience Inderpal S. Sarkaria,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer

Alexander H. Moskovitz, MD, Nabil P

Nutrition During Trimodality Treatment in Stage III Non-small Cell Lung Cancer: Not Only Important for Underweight Patients Barbara S. van der Meij,

A Review of First-Line Treatment for Small-cell Lung Cancer

Advances in mechanisms of allergic disease in 2016

Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.

Presentation transcript:

Volume 63, Pages 1-9 (December 2016) Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy Tom P. van der Laan, MD, René Iepsma, BSc, Max J.H. Witjes, MD, PhD, Bernard F.A.M. van der Laan, MD, PhD, Boudewijn E.C. Plaat, MD, PhD, Gyorgy B. Halmos, MD, PhD Oral Oncology Volume 63, Pages 1-9 (December 2016) DOI: 10.1016/j.oraloncology.2016.10.002 Copyright © 2016 The Authors Terms and Conditions

Fig. 1 Disease-specific survival (DSS) of sinonasal neuroendocrine carcinoma (SNC) per tumor type, stage and publication date. SNEC, well or moderately differentiated sinonasal neuroendocrine carcinoma; SNUC, sinonasal undifferentiated carcinoma; SmCC, sinonasal small cell carcinoma. Oral Oncology 2016 63, 1-9DOI: (10.1016/j.oraloncology.2016.10.002) Copyright © 2016 The Authors Terms and Conditions

Fig. 2 Disease-specific survival of sinonasal neuroendocrine carcinoma (SNC) per tumor type and treatment modality. The straight line represents the cohort in which the treatment modality was applied. Survival in months. SNEC, well or moderately differentiated sinonasal neuroendocrine carcinoma; SNUC, sinonasal undifferentiated carcinoma; SmCC, sinonasal small cell carcinoma. Oral Oncology 2016 63, 1-9DOI: (10.1016/j.oraloncology.2016.10.002) Copyright © 2016 The Authors Terms and Conditions